Aevi Genomic Medicine
Wayne
About Aevi Genomic Medicine
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $78.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2018)
- Ticker: nasdaq:GNMX
- Website: aevigenomics.com
- Phone: 1-610-254-4201
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/aevi-genomic-medicine-2225650 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.